Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.41% 0.00% 2.865B 45427.93
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
1.07% 6.00% 205.74M Upgrade

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped composed of U.S. equities in the healthcare sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name iShares
Prospectus Benchmark Index
Russell 1000 HC RIC 22.5/45 Cap TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Greg Savage 14.42 yrs
Jennifer Hsui 9.75 yrs
Amy Whitelaw 3.75 yrs
Paul Whitehead 0.41 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 6
205.74M
-3.341B Category Low
10.11B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of May 31, 2022

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of June 24, 2022. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
6.17%
-2.69%
22.28%
5.81%
20.80%
15.56%
23.41%
-9.15%
-0.87%
7.51%
22.40%
-8.71%
27.67%
15.90%
21.82%
-18.24%
5.98%
-6.03%
20.44%
2.83%
23.22%
12.75%
19.59%
-8.76%
7.12%
-3.21%
23.26%
5.58%
21.86%
18.27%
20.56%
-10.04%
6.84%
-2.76%
21.77%
6.28%
20.44%
13.34%
26.04%
-7.63%
7.07%
-3.41%
23.34%
5.53%
21.93%
18.16%
20.39%
-10.08%
As of June 24, 2022.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (6-24-22) 1.07%
30-Day SEC Yield (4-29-22) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 22.59
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of June 23, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of June 23, 2022

Asset Allocation

As of June 23, 2022.
Type % Net % Long % Short
Cash 0.22% Upgrade Upgrade
Stock 99.78% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Johnson & Johnson 9.53% 182.29 1.46%
UnitedHealth Group Inc 9.47% 495.64 -0.83%
Pfizer Inc 5.63% 51.59 2.99%
Eli Lilly and Co 5.34% 325.62 4.13%
AbbVie Inc 5.32% 152.34 1.93%
Merck & Co Inc 4.69% 93.13 1.23%
Thermo Fisher Scientific Inc 4.28% 544.81 0.78%
Abbott Laboratories 3.72% 109.45 3.05%
Bristol-Myers Squibb Co 3.41% 78.96 1.63%
Danaher Corp 3.26% 256.83 0.65%

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped composed of U.S. equities in the healthcare sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name iShares
Prospectus Benchmark Index
Russell 1000 HC RIC 22.5/45 Cap TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Greg Savage 14.42 yrs
Jennifer Hsui 9.75 yrs
Amy Whitelaw 3.75 yrs
Paul Whitehead 0.41 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (6-24-22) 1.07%
30-Day SEC Yield (4-29-22) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 22.59
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of June 23, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of June 23, 2022

Fund Details

Key Dates
Inception Date 6/12/2000
Last Annual Report Date 4/30/2021
Last Prospectus Date 9/1/2021
Attributes
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0